Bicara Therapeutics Inc. Operating Lease, Expense
Bicara Therapeutics Inc. (BCAX) had Operating Lease, Expense of $600.00 thousand as of 2025-06-03, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-11
- 2025-06-03: Operating Lease, Expense $600.00K.
- 2025-06-02: Operating Lease, Expense $500.00K.
- 2024-10-31: Operating Lease, Expense 1 month $1.10M; Operating Lease, Expense 1 month as first filed $600.00K.
| Period end | Operating Lease, Expense | Operating Lease, Expense 1 month | Operating Lease, Expense 1 month as first filed |
|---|---|---|---|
| 2025-06-03 | $600.00K 10-Q · filed 2026-08-11 | ||
| 2025-06-02 | $500.00K 10-Q · filed 2026-08-11 | ||
| 2024-10-31 | $1.10M 10-K · filed 2026-03-30 | $600.00K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |